e-learning
resources
Munich 2014
Monday, 08.09.2014
Epidemiology, pathogenesis and quality management of thoracic tumours
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The impact of lung cancer subtypes, smoking status and corticosteroid treatment on exhaled nitric oxide levels in patients with lung cancer
A. Bencova, M. Antosova, I. Kocan, E. Rozborilova (Martin, Slovakia)
Source:
International Congress 2014 – Epidemiology, pathogenesis and quality management of thoracic tumours
Session:
Epidemiology, pathogenesis and quality management of thoracic tumours
Session type:
Thematic Poster Session
Number:
2749
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Bencova, M. Antosova, I. Kocan, E. Rozborilova (Martin, Slovakia). The impact of lung cancer subtypes, smoking status and corticosteroid treatment on exhaled nitric oxide levels in patients with lung cancer. Eur Respir J 2014; 44: Suppl. 58, 2749
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Related content which might interest you:
The role of nitric oxide, reactive nitrogen and oxygen species in lung cancer
Source: International Congress 2015 – Developments in lung cancer diagnosis
Year: 2015
Can exhaled nitric oxide (FeNO) predict radiotherapy-induced lung toxicity in lung cancer patients?
Source: Annual Congress 2011 - Palliation and morbidity in lung cancer patients
Year: 2011
Increased levels of fractional exhaled nitric oxide after chemotherapy for lung cancer. Ongoing study
Source: Annual Congress 2010 - Prognostic factors for lung cancer
Year: 2010
Measurement of alveolar nitric oxide in patients with lung cancer
Source: Annual Congress 2012 - Screening, diagnosis, staging and treatment strategies for lung cancer
Year: 2012
The potential role of the pequi fruit (caryocar braziliense camb) in the prevention of lung cancer in an experimental model
Source: Annual Congress 2013 –Basic research on lung cancer
Year: 2013
Exhaled breath temperature in NSCLC: Could be a new non invasive marker?
Source: International Congress 2014 – Advances in diagnosis and therapy of thoracic tumours
Year: 2014
Exhaled nitric oxide: A biomarker for chronic lung allograft dysfunction?
Source: International Congress 2016 – Post-transplant complications: from animal models to the bedside
Year: 2016
The research on early detection of lung cancer with exhaled volatile organic compounds
Source: International Congress 2014 – Diagnosis, imaging and surgery for thoracic tumours
Year: 2014
Exhaled nitric oxide and asthma control: a longitudinal study in unselected patients
Source: Eur Respir J 2008; 31: 539-546
Year: 2008
Early detection of lung cancer in exhaled breath condensate using miRNA markers
Source: International Congress 2015 – Developments in lung cancer diagnosis
Year: 2015
Exhaled nitric oxide (eNO) and lung transplantation (LTx): impact of the native lung?
Source: Eur Respir J 2001; 18: Suppl. 33, 179s
Year: 2001
Exhaled nitric oxide in infants: a marker of inflammation?
Source: Eur Respir Monogr 2010; 49: 56-70
Year: 2010
Relation of asthma control and exhaled nitric oxide in patients with bronchial hyperresponsiveness to methacholine
Source: Annual Congress 2013 –New issues in lung function testing
Year: 2013
Exhaled nitric oxide after lung transplantation: impact of the native lung
Source: Eur Respir J 2003; 21: 429-432
Year: 2003
Exhaled nitric oxide reference values in healthy Tunisian adults
Source: Annual Congress 2013 –Various issues in clinical respiratory physiology
Year: 2013
The effect of montelukast on lung function and exhaled nitric oxide in infants with early childhood asthma
Source: Eur Respir J 2005; 25: 289-294
Year: 2005
Positive relationship between offline exhaled nitric oxide and lung clearance index in pre-school wheezers
Source: International Congress 2014 – Paediatric asthma: lung function testing and more
Year: 2014
Small airway dysfunction and its role in pediatric asthma control assessment
Source: International Congress 2016 – Techniques and tools in paediatric asthma
Year: 2016
Measurement of exhaled nitric oxide in patients with pulmonary tuberculosis
Source: Annual Congress 2013 –Diagnostic features of tuberculosis I
Year: 2013
Exhaled nitric oxide, susceptibility and new-onset asthma in the Children’s Health Study
Source: Eur Respir J 2011; 37: 523-531
Year: 2011
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept